Hepcidin is elevated in primary and secondary myelofibrosis and remains elevated in patients treated with ruxolitinib

Amy Zhou, Tim Kong, Jared S. Fowles, Chun Ling Jung, Maggie J. Allen, Daniel A.C. Fisher, Mary Fulbright, Elizabeta Nemeth, Tomas Ganz, Stephen T. Oh

Research output: Contribution to journalLetterpeer-review

5 Scopus citations
Original languageEnglish
Pages (from-to)e49-e52
JournalBritish Journal of Haematology
Issue number4
StatePublished - May 2022

Cite this